Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapyMeenu Sharma(The University of Texas MD Anderson Cancer Center), Willem W. Overwijk(Weatherford College)Nature CommunicationsJanuary 31, 202010.1038/s41467-020-14471-1Cited by 169SaveCiteExport RISWatch citationsRelated PapersBRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma|Clinical Cancer Research|2013|938